| ADR Ontology |
| ADR Term |
Secondary immunodeficiency |
| ADR ID |
BADD_A08218 |
| ADR Hierarchy |
|
| Description |
Not Available |
| MedDRA Code |
10054979 |
| MeSH ID |
Not Available
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Immunodeficiency secondary to chemotherapy (excl corticosteroids) | Immunodeficiency secondary to corticosteroids | Immunodeficiency secondary to measles | Immunodeficiency secondary to neoplasm NOS | Immunodeficiency secondary to oncology chemotherapy | Immunodeficiency secondary to radiation therapy | Immunodeficiency secondary to transplantation chemotherapy | Immunodeficiency secondary to trauma | Secondary acquired hypogammaglobulinaemia | Secondary acquired hypogammaglobulinemia | Secondary immunodeficiency | Immunodeficiency secondary to organ transplantation | Immunodeficiency secondary to chemotherapy | Immunodeficiency secondary to neoplasm | Secondary antibody deficiency |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
